Today: 19 July 2026
CapitaLand Investment share price holds at S$3.08 as February results line up for next week
31 January 2026
2 mins read

CapitaLand Investment share price holds at S$3.08 as February results line up for next week

Singapore, Jan 31, 2026, 15:12 SGT — Market closed

  • CapitaLand Investment wrapped up Friday unchanged, closing at S$3.08.
  • A director filing revealed a new share award linked to fees for FY2025.
  • Several CapitaLand-managed listed funds are set to report results in early February, just before CapitaLand Investment releases its full-year numbers.

CapitaLand Investment shares ended Friday steady at S$3.08, with roughly 13 million shares changing hands. The stock held firm following a flurry of filings and trust results late last week, setting the stage for a packed February ahead for the group.

As the market takes the weekend off, attention turns to early-week releases: earnings and distribution updates from the listed funds managed by the group, followed by CapitaLand Investment’s full-year results.

A notice dated January 5 on the Singapore Exchange laid out a tight schedule for upcoming reports: CapitaLand India Trust will release its results on Feb. 2 before the market opens. CapitaLand China Trust follows on Feb. 5, also before the open. CapitaLand Ascendas REIT reports later that day, but after the close. CapitaLand Integrated Commercial Trust is set for Feb. 6 before the open. CapitaLand Investment’s results come on Feb. 11, again before the market opens, with a results briefing scheduled for 9:00 a.m. and a live webcast.

In another filing, independent director David Su Tuong Sing revealed he acquired 25,009 shares at a reference price of S$2.543 each. The shares came from a transfer of treasury stock under the company’s restricted share plan, covering the share portion of directors’ fees for the year ended Dec. 31, 2025.

CapitaLand Ascott Trust, a major listed entity in the group, announced after Thursday’s close that income available for distribution climbed 11% to S$256.7 million for FY2025. Distribution per stapled security (DPS) remained steady at 6.10 Singapore cents. Managers confirmed the second-half payout will hit accounts on Feb. 27, with the record date set for Feb. 6. They also noted that S$23.2 million of non-periodic items were retained to fund asset enhancement and working capital. Chairman Lui Chong Chee said, “CLAS continued to deliver stable distributions despite ongoing macroeconomic uncertainties,” while CEO Serena Teo highlighted plans to focus on “recycling capital from divestments” to strengthen its living sector portfolio. SGX Links

CapitaLand Investment’s early-February update will reveal two key points: how distributions and valuations are faring within its listed platforms, and if debt costs remain steady as those vehicles refinance and move capital around.

There’s a catch. Real estate stocks often seem steady until results drop, then they can spike or fall sharply on minor changes in valuation assumptions, interest expenses, or currency moves. If the trusts deliver weaker guidance or asset values unexpectedly slip, the manager’s sentiment will likely take a hit too.

Friday’s director-share disclosures don’t serve as a trading signal on their own. They typically record share-based fee payments and awards under fixed terms, often appearing amid a flat tape for extended stretches.

Key events are coming fast: CapitaLand India Trust reports Monday, Feb. 2. Then China Trust and Ascendas REIT release results on Feb. 5. CapitaLand Integrated Commercial Trust follows on Feb. 6. CapitaLand Investment wraps up the sequence with its full-year report on Wednesday, Feb. 11, before the Singapore market opens.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • CSL Recovers A$16 Billion in Value, Trails Plasma Sector Gains This Week
    July 19, 2026, 3:25 PM EDT. CSL Limited (ASX:CSL) finished July 17 at A$123.32, rising 1.12% on the session and 0.35% for the week, recovering 37% from its 52-week low at A$90 and regaining roughly A$16 billion in valuation. However, CSL underperformed plasma specialists Grifols SA (+1.95%) and Takeda Pharmaceutical (+2.26%) in weekly movement. Trading volume for CSL on Friday came in 14% under its average as 1.62 million shares changed hands. The full-year financial results are due August 18. Still 55% beneath its 52-week peak, CSL's market value stands at A$59.06 billion. The group forecasts FY26 revenues near US$15.2 billion and NPATA of about US$3.1 billion, while a US$5 billion impairment remains subject to audit and board sign-off.
Imperial Brands share price slips as €900m bond terms land; buyback and dividend dates next for IMB
Previous Story

Imperial Brands share price slips as €900m bond terms land; buyback and dividend dates next for IMB

BAT share price: British American Tobacco stock heads into Monday with lawsuit cloud and results clock ticking
Next Story

BAT share price: British American Tobacco stock heads into Monday with lawsuit cloud and results clock ticking

Go toTop